Intracerebroventricular (i.c.v.)delivery of adiponectin improves peripheral insulin sensitivity and glucose homeostasis [49], suggesting that central actions of adiponectin may also influence metabolic diseases. The gene discussed is ADIPOQ; the disease is metabolic disease.